Determination of dimethylamine in biological samples by high-performance liquid chromatography. 1997

T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
Department of Clinical Chemistry, Free University Hospital, Amsterdam, Netherlands.

A reversed-phase HPLC method for the quantification of dimethylamine in serum and urine is presented. Dimethylamine (DMA) is converted into a stable fluorescent product by precolumn derivatization with fluorenylmethylchloroformate. The DMA derivative is resolved from derivatives of other amines and amino acids by gradient elution with a total run-time of 15 min. The lower limit of determination in biological samples is 0.1 micromol/l. Recoveries from spiked serum samples were 99-107%. Within- and between-run precision were better than 6%. Concentrations of DMA in serum from normal human subjects (n=8) and from continuous ambulatory peritoneal dialysis patients (n=15) were 3.3+/-1.5 and 29.1+/-12.1 micromol/l, respectively.

UI MeSH Term Description Entries
D007202 Indicators and Reagents Substances used for the detection, identification, analysis, etc. of chemical, biological, or pathologic processes or conditions. Indicators are substances that change in physical appearance, e.g., color, at or approaching the endpoint of a chemical titration, e.g., on the passage between acidity and alkalinity. Reagents are substances used for the detection or determination of another substance by chemical or microscopical means, especially analysis. Types of reagents are precipitants, solvents, oxidizers, reducers, fluxes, and colorimetric reagents. (From Grant & Hackh's Chemical Dictionary, 5th ed, p301, p499) Indicator,Reagent,Reagents,Indicators,Reagents and Indicators
D007676 Kidney Failure, Chronic The end-stage of CHRONIC RENAL INSUFFICIENCY. It is characterized by the severe irreversible kidney damage (as measured by the level of PROTEINURIA) and the reduction in GLOMERULAR FILTRATION RATE to less than 15 ml per min (Kidney Foundation: Kidney Disease Outcome Quality Initiative, 2002). These patients generally require HEMODIALYSIS or KIDNEY TRANSPLANTATION. ESRD,End-Stage Renal Disease,Renal Disease, End-Stage,Renal Failure, Chronic,Renal Failure, End-Stage,Chronic Kidney Failure,End-Stage Kidney Disease,Chronic Renal Failure,Disease, End-Stage Kidney,Disease, End-Stage Renal,End Stage Kidney Disease,End Stage Renal Disease,End-Stage Renal Failure,Kidney Disease, End-Stage,Renal Disease, End Stage,Renal Failure, End Stage
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010531 Peritoneal Dialysis, Continuous Ambulatory Portable peritoneal dialysis using the continuous (24 hours a day, 7 days a week) presence of peritoneal dialysis solution in the peritoneal cavity except for periods of drainage and instillation of fresh solution. CAPD,Continuous Ambulatory Peritoneal Dialysis
D002851 Chromatography, High Pressure Liquid Liquid chromatographic techniques which feature high inlet pressures, high sensitivity, and high speed. Chromatography, High Performance Liquid,Chromatography, High Speed Liquid,Chromatography, Liquid, High Pressure,HPLC,High Performance Liquid Chromatography,High-Performance Liquid Chromatography,UPLC,Ultra Performance Liquid Chromatography,Chromatography, High-Performance Liquid,High-Performance Liquid Chromatographies,Liquid Chromatography, High-Performance
D004123 Dimethylamines Derivatives of dimethylamine (the structural formula CH3NHCH3).
D005449 Fluorenes A family of diphenylenemethane derivatives.
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
August 1982, Journal of chromatography,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
May 1982, Journal of chromatography,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
August 1985, Analytical biochemistry,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
December 1998, Journal of chromatography. B, Biomedical sciences and applications,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
November 1987, Journal of chromatography,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
March 2003, Journal of chromatographic science,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
January 1986, Therapeutic drug monitoring,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
November 1981, Journal of chromatography,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
October 1988, Journal of chromatography,
T Teerlink, and M W Hennekes, and C Mulder, and H F Brulez
January 1994, Biomedical chromatography : BMC,
Copied contents to your clipboard!